Diplomat to Participate in Upcoming Investor Conferences
FLINT, Mich. – Feb. 21, 2017 – Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation’s largest independent specialty pharmacy, has announced that Phil Hagerman, chairman & CEO, will present at two upcoming investor conferences.
- Raymond James 38th Annual Institutional Investors Conference in Orlando, FL on Tuesday, Mar, 7, 2017, at 4:35 p.m. ET
- Barclays Global Healthcare Conference in Miami, FL on Tuesday, Mar. 14, 2017, at 2:35 p.m. ET
Live audio-only webcasts of the presentation and related presentation materials will be available on the investor relations section of the Company’s website at ir.diplomat.is. The archived webcast and presentation materials will also be available for 90 days at the same URL.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
Bob East, Westwicke Partners
443.213.0500 | firstname.lastname@example.org
Jenny Cretu, Diplomat
810.768.9370 | email@example.com
@DiplomatRxDiplomat to Release Third Quarter 2017 Operating Results and Host Conference Call on Monday, November 6, 2017 https://t.co/eqa2MVeQAR15 hours ago
@USPharmacopeiaRT @USPharmacopeia: At USP Student Pharmacists Career day, Stephanie LaPointe of @DiplomatRx discusses impact of specialty pharmacy service…3 days ago
@NelufarMohajeriRT @NelufarMohajeri: Specially Pharmacy has great impact on patient health. Thanks Stephanie LaPointe of @DiplomatRx @USPharmacopeia #quali…4 days ago
@DiplomatRxWe are hiring several clinical pharmacists at a number of our locations. Browse our openings and apply today at… https://t.co/UZlAMjaTDz5 days ago
@DiplomatRxDiplomat Selected to Dispense VERZENIO™ for Breast Cancer https://t.co/vOXZcaBM366 days ago